UNSPSC 51161554: Ritolukast

This classification denotes an anti-asthmatic agent with the molecular formula C17H13F3N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0E8R4GDE2Q, chemically known as 1,1,1-trifluoro-alpha-2-quinolylmethanesulfon-m-anisidide but generally known as ritolukast, which bears US NIH Compound Identifier 60539. European Medicines Agency schedules Ritolukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10341MIG.

UNSPSC 51161554 Ritolukast is a Commodity code covering a specific pharmaceutical active ingredient used in respiratory treatments. State and local governments procure ritolukast primarily through their health and human services departments, Medicaid agencies, and public health systems to support asthma and allergic airway disease management programs. The product appears in formulary procurement and bulk pharmaceutical purchasing for public clinics, emergency departments, and community health centers serving Medicaid-eligible and uninsured populations. Issuing bodies include state health departments, county health systems, and municipal hospital authorities; school districts and transit authorities do not typically purchase this pharmaceutical directly.

The source provides no records of recent state and local contract opportunities posted under this code. Without posted solicitations, bids, or awarded contracts, activity level and geographic concentration cannot be determined from available data. Firms pursuing pharmaceutical supply contracts to state and local health agencies should monitor requisitions through primary state Medicaid procurement channels and cooperative purchasing vehicles such as state group purchasing organizations (GPOs) rather than expect standalone RFP or IFB notices at the individual active-ingredient level.